APOE2 and APOE3: what the other alleles mean

Almost everything written about the APOE gene is really about ε4, the risk-raising version. But you have two alleles, and most people carry at least one copy of ε3 or ε2. If your result includes one of those, you deserve to know what it actually means, not just “the one that isn’t ε4.” The short version: ε3 is the neutral default, and ε2 is genuinely protective against Alzheimer’s, with one catch on the heart side. Here is the full picture.

A quick reminder of how APOE works

APOE makes a protein that packages and transports cholesterol and fats through the blood and brain. The three common versions differ by tiny changes that alter how well the protein does that job, which is why they shift risk for both Alzheimer’s and heart disease. You inherit one allele from each parent; how the pair combines is covered in the genotypes explained.

APOE3: the neutral default

ε3 is the most common allele worldwide, carried by the majority of people, and it is the reference that ε2 and ε4 are measured against. If you are 3/3, you have average APOE-related risk: roughly a 10 to 15% lifetime risk of Alzheimer’s dementia by age 85, neither elevated by this gene nor specially protected by it.

That is genuinely reassuring on the APOE axis, but it is not a free pass. APOE explains only part of overall Alzheimer’s risk. The 2024 Lancet Commission estimates that about 45% of dementia cases are tied to modifiable factors you can act on, so the same levers still matter for a 3/3 person. APOE is one input, not the whole story.

APOE2: protective, with a real catch

ε2 is the rarest of the three (roughly 5 to 10% of alleles) and the most protective against Alzheimer’s. The signal is not subtle. In a 5,000-person neuropathology study, people with two copies (the 2/2 genotype) had an odds ratio of about 0.13 versus 3/3, meaning roughly a 90% lower likelihood of Alzheimer’s. Set the two extremes side by side and the gene’s full range is stark: in that same study, 2/2 carriers had a roughly 99.6% lower risk than 4/4 carriers. The mechanism is the mirror image of ε4. The ε2 protein binds the brain’s APOE receptors well and appears to clear amyloid efficiently.

The catch is on the heart side, and it is the part people miss. The ε2 protein binds the LDL receptor very poorly, something like 50- to 100-fold weaker than ε3. When that clearance route is sluggish, cholesterol-rich remnant particles can back up in the bloodstream instead of being cleared out. In most ε2 carriers this is mild or invisible. But in a small subset, almost always 2/2 homozygotes and usually only when a second trigger is present (diabetes, obesity, hypothyroidism, or estrogen changes), it tips into a lipid disorder called type III hyperlipoproteinemia, marked by elevated triglycerides and those remnant particles. It develops in only a few percent of 2/2 carriers and is rare in 2/3, so this is a “know it exists and check your panel” footnote, not a reason for a 2/3 carrier to worry. Good for the brain, occasionally complicated for the lipids.

What each result means in practice

• 3/3: average APOE risk. Work the standard levers; you are neither flagged nor exempt.
• 2/3: below-average Alzheimer’s risk. Reassuring, with the same general lifestyle advice.
• 2/2: lowest Alzheimer’s risk, but worth a look at your lipids (triglycerides in particular) given the rare lipid-disorder link.
• 2/4: the ε2 only partly offsets the ε4. Treat it as intermediate but elevated; some studies put it closer to 3/4 than to average.
• Any ε4 (3/4, 4/4): the higher-risk genotypes that the rest of this site focuses on.

Common questions

Is APOE2 always good news? Mostly. It is protective against Alzheimer’s, which is the headline. The asterisk is a rare lipid disorder in some carriers, so 2/2 carriers in particular should keep an eye on triglycerides with a clinician.

I’m 3/3. Do I still need to worry about any of this? You are at average APOE-related risk, which is good, but Alzheimer’s and heart disease have many other inputs. The levers still pay off. You just are not starting from a genetic disadvantage on this gene.

Can I have one protective and one risk allele? Yes, that is 2/4. The ε2 appears to partly counter the ε4, but the offset is partial. Plan for intermediate-but-elevated risk rather than assuming the ε2 cancels the ε4.

Whatever your pair, your genotype is a starting point, not a verdict, and the day-to-day levers matter across all of them. This is general education, not medical advice; interpret your result with a clinician or genetic counselor.